Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18788868 | 0.87 | TSHR (0.62) | SMN1; SMN2AKR1B1KMT2AIDO1DPP4 | |
| SCHEMBL3148086 | 0.85 | SMN1; SMN2 (0.46) | SMN1; SMN2TAAR1AKR1B1KMT2AIDO1 | |
| SCHEMBL17055847 | 0.85 | KDM4E (0.53) | SMN1; SMN2TAAR1AKR1B1KMT2AKDM4E | |
| SCHEMBL28905460 | 0.84 | SMN1; SMN2 (0.40) | SMN1; SMN2TAAR1AKR1B1IDO1KDM4E | |
| SCHEMBL925766 | 0.82 | SMN1; SMN2 (0.43) | SMN1; SMN2TAAR1AKR1B1KMT2AKDM4E | |
| SCHEMBL10457899 | 0.82 | TAAR1 (0.43) | SMN1; SMN2TAAR1AKR1B1KMT2AKDM4E | |
| SCHEMBL15614733 | 0.80 | ADRB2 (0.49) | SMN1; SMN2TAAR1AKR1B1KMT2AKDM4E | |
| SCHEMBL19879617 | 0.80 | SMN1; SMN2 (0.42) | SMN1; SMN2TAAR1AKR1B1KMT2AKDM4E | |
| SCHEMBL4250565 | 0.80 | AKR1B1 (0.48) | SMN1; SMN2TAAR1AKR1B1KMT2AKDM4E | |
| SCHEMBL13108637 | 0.79 | SMN1; SMN2 (0.48) | SMN1; SMN2TAAR1AKR1B1KMT2AIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108623561-B | Method for preparing panenonic acid compound | 中国海洋大学 | 2025-04-01 | — | — | CN | claimed |
| WO-2021216722-A1 | STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES | Atea Pharmaceuticals, Inc. (US) | 2021-10-28 | — | — | WO | claimed |
| US-12551570-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2026-02-17 | — | — | US | disclosed |
| US-12479927-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2025-11-25 | — | — | US | disclosed |
| EP-4604951-A1 | 1-(SULFONYL)-N-PHENYLPYRROLIDINE-2-CARBOXAMIDES DERIVATIVES AND USE THEREOF | AMIRA THERAPEUTICS, S.L. (ES) | 2025-08-27 | — | — | EP | disclosed |
| US-20250213712-A1 | ANTIBODY DRUG CONJUGATES COMPRISING CAMPTOTHECIN DERIVATIVES AND USES THEREOF | INTOCELL, INC. (KR) | 2025-07-03 | — | — | US | disclosed |
| CN-113454124-B9 | Combination therapies for ARM and natural killer cells | 克莱奥药品有限公司 | 2025-05-30 | — | — | CN | disclosed |
| US-12274898-B2 | Substituted benzodiazepines as antibody-drug conjugates | INTOCELL, INC. (KR) | 2025-04-15 | — | — | US | disclosed |
| CN-108623561-B | Method for preparing panenonic acid compound | 中国海洋大学 | 2025-04-01 | — | — | CN | disclosed |
| CN-113454124-B | Combination therapies for ARM and natural killer cells | 克莱奥药品有限公司 | 2025-03-11 | — | — | CN | disclosed |
| EP-4452328-A1 | ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF | Intocell, Inc. (KR) | 2024-10-30 | — | — | EP | disclosed |
| WO-1987006594-A1 | POLYAMIDE RESIN AND METHOD FOR PREPARATION OF REAGENTS FOR IMMUNODIAGNOSTIC USE | SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH (US) | 1987-11-05 | — | — | WO | disclosed |
| US-4617149-A | ANIMAL GROWTH REGULATORS | ELI LILLY AND COMPANY (US) | 1986-10-14 | — | — | US | disclosed |
| EP-0044605-B1 | FUNGICIDAL BIS-AZOLYL COMPOUNDS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1986-02-12 | — | — | EP | disclosed |
| US-4523019-A | INTERMEDIATE FOR FUNGICIDE AND PLANT GROWTH REGULATOR | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-06-11 | — | — | US | disclosed |
| EP-0138416-A2 | Growth hormone release factor analogs | ELI LILLY AND COMPANY (US) | 1985-04-24 | — | — | EP | disclosed |
| US-4490364-A | STIMULANTING GALL BLADDER CONTRACTION, ANTISECRETORY AGENT, ANTICONVULSANT | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1984-12-25 | — | — | US | disclosed |
| US-4416682-A | 1,3-Bis(azolyl)propanols as fungicides and plant growth regulators | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-11-22 | — | — | US | disclosed |
| EP-0044605-A1 | Fungicidal bis-azolyl compounds | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1982-01-27 | — | — | EP | disclosed |
| US-3960828-A | Catalytic hydrogenolysis of protected sulfur containing peptides | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250213712-A1 | ANTIBODY DRUG CONJUGATES COMPRISING CAMPTOTHECIN DERIVATIVES AND USES THEREOF | CD47, TOP2A, SSB | SMN1; SMN2 4272/4885TAAR1 4686/4885AKR1B1 3234/4885 |
| US-12551570-B2 | Compounds comprising cleavable linker and uses thereof | FCGR2A, FCGR3B, FCGR1A | SMN1; SMN2 3041/4885TAAR1 1883/4885AKR1B1 3724/4885 |
| US-12479927-B2 | Compounds comprising cleavable linker and uses thereof | VIP, ANTXR2, TNFRSF9 | SMN1; SMN2 2658/4885TAAR1 1935/4885AKR1B1 4402/4885 |
| US-12274898-B2 | Substituted benzodiazepines as antibody-drug conjugates | GABRA3, GABRA6, GABRA4 | SMN1; SMN2 1564/4885TAAR1 365/4885AKR1B1 1338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.